Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 3/2014

Content (17 Articles)

editorial

ASH 2013: constant progress: not only for B-cell neoplasms

Michael Steurer

editorial

The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent

Georg Pall

short review

Highlights of the American Society of Hematology Meeting 2013: hemostaseology

Clemens Feistritzer, Sophie Maria Wildner

short review

Aggressive lymphoma at ASH 2013: R-CHOP under attack?

Thomas Nösslinger

short review

Myelodysplastic syndromes (MDS)

Sonja Burgstaller

short review

ASH 2013: short review on myeloproliferative neoplasms

Stefan Schmidt

short review

ASH Update 2013: chronic lymphocytic leukemia and indolent lymphoma

Michael Steurer

short review

Molecular monitoring of minimal residual disease in acute leukemia

Otto Zach, Johannes Clausen

short review

Venous thromboembolism in children with acute lymphoblastic leukemia

Jolanta Skalska-Sadowska, Katarzyna Derwich

short review

The role of maintenance strategies in breast cancer

Elisabetta Munzone, Marco Colleoni

original report

Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India

K. C. Lakshmaiah, Umesh Das, K. Govind Babu, T. M. Suresh, D. Lokanatha, Linu A. Jacob, Suresh Babu, G. Mukherjee, M. Vijayakumar

special report

Challenges with overall survival as an endpoint for efficacy assessment in first line metastatic breast cancer randomized controlled clinical trials and the investigation of truncated overall survival as an alternative endpoint

Colin Neate, Alexander Strasak, Hans Ulrich Burger, Barbara Tong, Lee Kaiser

short review

Neoadjuvant chemotherapy for soft tissue sarcoma

Ewald Wöll

review

Importance of intraoperative radiation therapy in the treatment of soft tissue sarcoma: data at hand

Arpad Sztankay

short review

Surgical aspects in the treatment of retroperitoneal soft tissue sarcomas

Alexander Perathoner, Reinhold Kafka-Ritsch, Matthias Zitt

special report

Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations

Cathrin Balmelli, Michael Mark, Christian Spirig, Vito Spataro, Stefanie Pederiva, Christian Monnerat, Alfred Zippelius, Andreas Wicki

short review

Colorectal cancer: screening and some notes on the prevention

Paul Bergmeister, Alois Hermann Lang

May 14
Issue: 2/2014
Dec 14
Issue: 4/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits